Use of vasodilator drugs in the treatment of diabetic arteriosclerosis obliterans.
D001161:Arteriosclerosis; D001162:Arteriosclerosis Obliterans; D048909:Diabetes Complications; D003920:Diabetes Mellitus; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D011725:Pyridines; D013565:Sympatholytics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
ARTERIOSCLEROSIS; DIABETES MELLITUS/complications; PYRIDINES/therapeutic use; SYMPATHOLYTICS/therapeutic use; VASOMOTOR DRUGS/therapeutic use